PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2024
Injecting Innovation into Drug Delivery
Educational Sessions | Training Courses | Networking Opportunities | Exhibit Hall | Drug Delivery Innovation Awards
Become a Sponsor and/or Exhibitor
Learn about groundbreaking innovation in injectable drug delivery at the 21st edition of the annual PDA Universe of Pre-Filled Syringes and Injection Devices Conference!
The largest event on pre-filled syringes and injection devices brings together key field players to discuss the breakthroughs that are propelling the industry forward.
This conference is the top platform to hear top-notch content, exchange knowledge with other experts, and contribute to enhancing global health within the pharmaceutical and medical device sectors.
A comprehensive agenda covers critical topics, including sustainability, large-volume injections, digital health, and regulatory compliance. One key conference highlight is the interactive exhibit hall featuring 120+ vendors and service providers introducing new technologies and partnerships.
Additionally, forward-thinking poster presentations, lightning sessions, lively Q&A sessions, networking activities, and the Drug Delivery Innovation Awards make this event a must-attend.
Following the conference, join specialized training to bridge theory to practice.
Mark your calendar for an unforgettable experience at the world's leading event in drug delivery!
Highlighted Presenters
Key Presenters
-
Andrea Redd
Eli Lilly and Company
Associate Vice President, Global Regulatory Affairs, Drug Device Delivery
PresenterRead Bio
Conference Co-Chairs
The Minds Behind the Insights
-
Alessandro Morandotti
Stevanato Group
Drug Containment Solutions Product Development Director
Read Bio
Program Planning Committee
The Team Behind the Event's Agenda
Schedule
Discover What's Happening Each Day
07:00 – 18:00
Registration Open
07:15 – 08:15
Continental Breakfast
08:15 – 10:00
P1: Regulatory Landscapes and Strategies for Combination Products
Moderator: Theresa E. Bankston, PhD, VP Combination Products & Capabilities, BD
Navigating the complex and evolving requirements for combination products is a challenging and critical undertaking for many parenteral therapeutics. In this plenary session, we will provide an update on the latest regulatory developments and guidance for combination products, discuss common pitfalls in their development and approval, and share lessons learned, best practices, and helpful strategies from case studies. The audience will also benefit from industry perspectives shared by the CPC Bridging Working Group on bridging in relation to device platforming. Join us for the integrated panel discussion/Q&A to engage in a dialogue on these and other critical regulatory topics.
08:15
Opening Remarks from Conference Co-Chairs and Awards Presentations
08:45
Evolution of Combination Product Requirements to Support Innovation
Andrea Redd, Associate Vice-President, Global Regulatory Affairs, Drug Delivery and Combination Products, Eli Lilly and Company
09:10
Bridging Strategies for Combination Products
Desiree Crisolo, Sr. Director, Head of Global Regulatory CMC Policy and Intelligence, Biogen
09:35
Q&A
10:00 – 16:30
Exhibit Hall Open
10:00 – 11:00
Networking Break, Tech Talks, and Guided Poster Walk in the Exhibit Hall
10:00 –11:00
Exhibitor Tech Talks
10:10
SHL Medical's Elexy™: Expanding True Autoinjector Versatility for the Development of Combination Products
Vince Masciopinto, Director, Customer Solutions SHL Medical
10:25
Enabling High-Volume Drug Delivery with a Platform Approach
Gurmeet Singh, MBA, Senior Director West Pharmaceutical Services
10:40
Benefits of Utilizing a Digital Validation Process for Parenteral Inspection Systems
Karen Granzow, Senior Consultant, Koerber Pharma, North America
11:00 – 12:30
P2: Current Opportunities and Challenges with Large Volume Injections – Market Overview and Delivery Options with focus on Injection Tolerability and Pain
Moderator: Jakob Lange, PhD, VP & Head of Account and Business Development, Ypsomed AG
This session will explore the emerging field of large volume injections and provide a market overview and delivery options, i.e., subcutaneous injections of volumes larger than 2 ml. We will begin with an overview of the drugs in development, presenting results of a recent detailed analysis of the clinical trial registers.
This will be followed by a presentation covering options for hand-held, large volume injections including data from recent studies on the tolerability of such high-rate injections. Finally, we will hear results on tolerability and pain of very high-volume injections (up to 25 ml or more) using on-body and near-body delivery solutions. After the presentations, we will conclude with a panel discussion, including a patient on the challenges and opportunities in the field.
11:00
Overview of the Industry's Pipeline of SC Drugs in Development Above 2ml Injection Volume
Phil Green, PhD, President, Chesapeake Pharma
11:20
Challenges and Opportunities with Rapid Handheld Injections (> 2mL) and the Clinical Tolerability of a 10 mL High-Volume Auto-Injector
David W. Kang, Director, Innovation, Halozyme, Inc.
11:40
Pain & Tolerability of Large Volume Subcutaneous Injection
Galen Shi, PhD, Vice President of Engineering – Delivery Devices, Eli Lilly and Company
12:00
Q&A with Additional Panelist
Rana Mogannam, Patient Advocate, Patient Pavilion (Booth 1029)
12:30 – 14:00
Networking Lunch and Tech Talks in the Exhibit Hall
12:40 –13:35
Exhibitor Tech Talks
12:40
Accelerating Your Vial to PFS Pathway
Flora Felsovalyi, PhD, Associate Director, Lonza
12:55
Ypsomed's Perspective on Industry Partnering for Successful Combination Products
Philipp Richard, MSc, MBA, Account & Business Development Manager, Ypsomed AG
13:10
A New Frontier: Self-Administration of Lyophilised, Large-Volume, Subcutaneous, Biologics
Daniel Waites, Director, Research & Development, Koerber Pharma, North America
14:00 – 15:30
Concurrent Sessions
A1: Putting the User First - The Human Side of Product Development
Moderator: Bart E. Burgess, Global Head, Portfolio Strategy and Customer Solutions, SHL Medical AG
Human factors remain a source of uncertainty for combination product developers and suppliers. More than ever, careful planning is required to increase the probability of program success. This session will present new perspectives on incorporating user capability inputs, designing a product holistically, and incorporating technologies once they arrive from outside your organization.
14:00 | Holistic Design Approach for Combination Products: Patient, Product, Device, and Packaging
- Agata Pczycka, Principal Engineer, Packaging Development & Technology, AstraZeneca
- Lucy Baldwin, Head of Research & Strategy, Kinneir Dufort a SteriPack Company
14:20 | Quantification of User Inputs During Injection Device Use: An Anthropometric Human Factors Study
Enrica Papi, PhD, Human Factors Manager, GSK
14:40 | Navigating Human Factors Challenges: Lessons Learned from Combination Product Acquisitions
Esther Foo, PhD, Senior Scientist, Merck
15:00 | Q&A
B1: Autoinjector - One Size Doesn't Fit All
Moderator: Dominik Ziegler, MSc, Executive Director Device Technology Device Technology Solution Center, Novartis Pharma AG
The rising interest in high doses for subcutaneous drug delivery is fueling the development of high volume/high viscosity autoinjectors for rapid and convenient dose delivery. This session will explore the design space of autoinjectors in combination with formulations and primary packaging. Additionally, we will discuss novel solutions for primary packaging and autoinjectors, focusing on sustainability, cost, and usability.
14:00 | High-Dose Drug Delivery: How Far Can Autoinjectors Go?
Iain Simpson, PhD, Director, Global Pharma Segment, Phillips Medisize
14:20 | A Summative Report on Exploratory Studies and Collaborative Developmental Work Toward Understanding Large Volume Subcutaneous Autoinjections
- Gary Calderwood, Senior Product Manager, SHL Medical
- Robert Lindner, PhD, Global Product Manager Bulk and Sterile Cartridges, SCHOTT Pharma
14:40 | Reusability Simplified: The Journey to Develop a Sustainable, Low-Cost Reusable Autoinjector
- Duncan Paterson, Senior Director, Device Development, AstraZeneca
- Michael Herd, MEng, Senior Engineering Consultant, Team Consulting
15:00 | Q&A
C1: How to Prioritize and Optimize Quality Control
Moderator: Brigitte Reutter-Haerle, Vice President Product Management & Marketing, Vetter
Quality control is paramount in injectable manufacturing, and emerging technologies are creating new techniques to optimize it. This session reviews examples of innovative strategies that advance QC capabilities, prioritize timelines, and promote packaging integrity. The presentations will also explore AI applications for injectable manufacturing quality control and how these innovations relate to regulatory compliance in parenteral product manufacturing.
14:00 | Unlocking the Potential of AI Visual Inspection and Data Analytics to Revolutionize Quality Control in Pharmaceutical Manufacturing
Garth Conrad, MBA, VP Quality, Health Solutions, Flex
14:20 | The Impact of Varying Concurrent Transport Hazards on Plunger Movement
Robert Battista, Engineering Manager, Modality Solutions
14:40 | New Solutions for Quality Control of Difficult-to-Inspect Parenterals
Matthias Kahl, PhD, Head of R&D and Lab Services, WILCO AG
15:00 | Q&A
15:30 – 16:30
Networking Break, Tech Talks, and Guided Poster Walk in the Exhibit Hall
15:40 –15:50
Exhibitor Tech Talks
15:40
Sterile Product Introduction and Tech Transfers in a Crowded Market
Kimberly S. Brown, Director, Client Portfolio and Relationship Management, Kindeva Drug Delivery
15:55
Pre-Filled Syringe Considerations for VHP Sterilization
Juha P. Mattlia, MEng, Senior Manager, Technical Services, STERIS Life Sciences
16:10
Integration of Primary Container Solutions with CDMO Services for Biotech Parenteral Drug Products
Jianxiu Zhao, PhD, Senior Technology Development Manager, Terumo
16:30 – 18:00
Concurrent Sessions
A2: Computational Tissue Modeling and Simulation Techniques for Drug Formulations and Injection Devices
Moderator: Philippe Lauwers, Technology Development Director, Terumo Pharmaceutical Solutions
Computational tissue models help build our understanding of injection site pain and the impact of patient, drug formulation, injection device on the overall patient experience.
These digital tools may also minimize the need for extensive clinical studies reducing patient burden and providing valuable time and cost savings to the pharmaceutical industry.
In this session, we will also discuss how simulation tools enhance the performance and reliability of complex engineering systems; ranging from primary container components and injection devices up to automated assembly equipment.
16:30 | Computational Tissue Simulation to Predict Pain, Tolerability, and Acceptability of Drug Formulations and Injection Devices
- Katharina Clitherow, PhD, Principal Device Engineer, GSK
- Joel A. Gresham, Lead Engineer, Crux Product Design
16:50 | Computational Modeling of Large Volume, High-Viscosity Subcutaneous Injections
Scott Lovald, PhD, Senior Managing Engineer, Exponent
17:10 | Application of Advanced Simulation Techniques for Drug Delivery Devices: From Micro to Macro
Tommaso Borghi, Director Product Development - Drug Delivery Systems, Stevanato Group
17:30 | Q&A
B2: Large Volume Subcutaneous Injections (LVSC) Advancements
Moderator: Christian Helbig, Vice President Glass Syringe Business, SCHOTT Pharma AG
Dive into large volume subcutaneous drug delivery advancements. This session provides valuable knowledge to enhance the patient experience, improve adherence, and drive pharmaceutical innovation.
We will focus on the benefits and challenges of permeation enhancers, how on-body injection devices can help to transform delivery larger than 2 mL, and the challenges of overcoming the subcutaneous administration of a small molecule, high viscosity long-acting HIV treatment.
16:30 | Expert Insights into the Development of Large Volume Subcutaneous Drugs with Permeation Enhancers: A Survey Examining Challenges, Alternatives, and Future Directions
Mehul Desai, PharmD, MBA, Vice President, Medical Affairs, Enable Injections
16:50 | Opportunities and Challenges of Large Volume Parenteral Subcutaneous Delivery and How On-Body-Injectors Enable Innovative Medicines
- Hanns-Christian Mahler, PhD, Chief Enablement Officer, ten23 health
- Reto Jost, Director, Category Lead Large Volume Injectors, Ypsomed AG
17:10 | Development of a Small Molecule, High Viscosity, High PH Injectable for HIV Treatment
Scott Nunn, MS, MBA, Director, Device Engineering, Gilead Sciences
Alasdair Young Director, Device Engineering, Gilead Sciences
17:30 | Q&A
C2: Digital Solutions for Self-Injection and Home Use
Moderator: Laurent Jeanmart, PhD, Head of Technical Services, GSK
This session explores the development of digital systems for patient self-administered injections, focusing on the challenges of dealing with regulatory requirements and multiple business partners. We will discuss the integration of combination products like autoinjectors with digital monitoring devices, mobile applications (SaMD), doctor portals, and cloud storage systems. Emphasis will be placed on the need for establishing clear regulatory strategies, QMS boundaries, and roles early in the process.
We will also address the cost considerations of adding connectivity to drug delivery devices, sharing experiences from the consumer tech industry. Additionally, usability studies and clinical feasibility results from a digital health program co-developed by Sidekick Health and Ypsomed will be presented, showcasing the program's success in providing therapy insights, patient education, and support.
Join us for insights into development practices, regulatory strategies, and the potential of digital health programs to enhance self-injection therapy management.
16:30 | Designing Cost-Effective Smart Devices: A Key Hurdle to Success
Hans Jensen, MBA, Business Development Lead, Cambridge Design Partnership
16:50 | Navigating the Complexities in Developing Digital Solutions for Home Use
- Jack Zhang, Associate Director, Digital Product Quality, Bristol-Myers Squibb
17:10 | Exploring Patient Insights: Developing a Digital Health Program for Self-Injection Therapies Through Usability Studies
Guy Shauli, Senior Director Pharma Partnerships, Sidekick Health
17:30 | Q&A
16:30 – 18:30
Mini Training Course: Pharmaceutical Elastomers and Closures
Trainer: Gabrielle Gehron, Technical and Scientific Expert, Datwyler
Pharmaceutical elastomers are commonly applied in the form of stoppers, plungers, and O-rings for parenteral drug-delivery applications. Here, good sealing is an apparent property for effective drug containment; however, there are several other critical attributes that govern the selection of an appropriate elastomeric component for safe and efficacious drug-delivery.
In this training course, you will gain insight into the fundamentals of pharmaceutical elastomers with practical considerations. Industry experts will describe component selection strategies, review manufacturing technologies, component processing and sterilization techniques. There will be a focus to understand the origin of defects and analytical tools applied for their characterization.
19:00 – 22:00
Networking Reception
Location and Travel
Venue Details and Accommodations
PLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.
Conference Venue & Hotel Accommodations
Phoenix Convention Center - South Building
33 S 3rd StreetPhoenix, AZ 85004, United States
In Greater Phoenix, innovation is a way of life. Since ancient times, the Sonoran Desert has evoked inspiration, adaptation, collaboration, and innovation. This spirit is an indelible part of the identity and inspires the approach to agriculture, technology, sustainability, hospitality, education, medicine, business and so many other aspects that continue to shape Phoenix's future.
The result? Business is booming in the nation’s fifth-largest city. Technological and software companies are putting down roots at a rapid pace. Leading minds in energy, medicine, transportation, and other industries see Phoenix as a landscape for turning cutting-edge ideas into tools and products that the world benefits from!
Additional Hotel Information
Renaissance Phoenix Downtown (HQ)
Westin Downtown Phoenix
Residence Inn Phoenix Downtown
Courtyard Phoenix Downtown
All hotels are currently SOLD OUT at the group rate. For additional availability, please reach out to each hotel directly.
Cancellation PolicyIndividual reservations cancelled within seventy-two (72) hours prior to arrival will forfeit one night's room deposit. Individuals will be responsible for payment of their own cancellation fees.
How to Get Here
Registration
Pricing Options
Standard Registration
Register after 28 August 2024
Member Price
$2,895GovernmentMember Only
$995
Health AuthorityMember Only
$995
Early Career ProfessionalMember Only
$1,495
StudentMember Only
$695
AcademicMember Only
$995
Non-Member
$3,295
GROUP REGISTRATION DISCOUNT: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.
GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.
CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to registration@pda.org.
Presenters
Meet Our Presenters
Promotion and Press
Promote the Conference
Get Shareable Images and PostsRequest Press Pass
Submit Your InformationSponsors
Diamond Sponsors
Flex
Platinum Sponsors
Flex
Gold Sponsors
Flex
Silver Sponsors
Flex
Bronze Sponsors
Flex
Exhibitors
Flex
Flex
Media Partners
Flex
Become a Sponsor and/or Exhibitor
Amplify Your Presence and Reach Your Customers!
Drive innovation and connect with a targeted audience of industry leaders at the world's premier pre-filled syringe and injection device conference. Sponsorship opportunities offer unparalleled brand visibility, networking with key decision-makers, and the chance to position your company at the forefront of this dynamic field.
Become a SponsorPut your cutting-edge technologies and solutions in front of a global audience of Drug Delivery professionals. The conference's interactive exhibit hall provides the perfect platform to connect with potential customers, generate leads, and forge valuable partnerships. Don't miss this opportunity to showcase your expertise and propel your business forward.
Reserve Your Exhibit SpaceHave a question or need assistance?
Send us a message, and our team will get back to you shortly. We're here to help!
Your rating for this document has already been submitted